US$ 24.33
bpc 157 clinical trials canada BPC-157 + TB-500 | The Peptide Labs BPC-157 and Its Role in
Description
After the desired confluence was reached, the K562 cells were incubated in tissue culture dishes for 24 hours with concentrations of PNC-27 ranging from 25

This mechanism is also the source of cancer-related concerns (more below)

KLOW vials are typically 80 mg and require a different dosing protocol because of the added peptide mass

Avoid sustained direct UV or strong visible light
